Barclays Maintains Overweight on Exelon, Raises Price Target to $39
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Nicholas Campanella has maintained an Overweight rating on Exelon (NASDAQ:EXC) and increased the price target from $36 to $39.
March 14, 2024 | 11:37 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Barclays has maintained an Overweight rating on Exelon and raised the price target from $36 to $39.
The upgrade in price target by Barclays, a major financial institution, indicates a positive outlook on Exelon's stock. This is likely to instill confidence among investors, potentially driving up the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100